Study offers insight into incarceration’s toll on youth health

Hav­ing ex­haust­ed near­ly all oth­er av­enues to get its ALS cell ther­a­py ap­proved, Brain­Storm Cell Ther­a­peu­tics is heav­ing a Hail Mary pass. The biotech an­nounced

Der­ma­vant re­port­ed new Phase III da­ta for its atopic der­mati­tis cream Vta­ma on Thurs­day morn­ing, say­ing more than 80% of par­tic­i­pants across two stud­ies saw

Share this article A new study highlights that 5 out of 100 children born to fathers treated with valproate during conception were diagnosed with a